IDEAYA Biosciences, Inc.
IDYABiotechnology
$31.96−2.83%As of Oct 30vs prior close
- Market cap
- $3.1B
- P/E (TTM)
- –
- From 52W high
- −24.76%
- EPS (YE25)
- -$1.28
- Revenue (YE25)
- $218.7M
- Net margin
- -51.99%
- Dividend yield
- 0.00%
Nomior Score
54
Steady ProfileSpeculativeTop 39% of the scored universe
Growth—
Quality55
Value57
Momentum64
Resilience41
Growth
$218.7Mrevenue, YE25
YE19 $0YE25 $218.7M
Connections
Revenue to profitQ2 YE26
The operating loss was 1381% of revenue.
Who owns it
2funds